Clinical Trial Update: Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial conducted by the University of Texas at Austin is investigating multimodal brain biomarkers to guide treatment selection for major depr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Major Depressive Disorder Recurrent

Snippet

Sponsor: University of Texas at Austin | Conditions: Major Depressive Disorder, Chronic Major Depression, Recurrent | Phase 4 | Status: RECRUITING